Porton USA LLC

About Porton USA LLC

Founded in 2005, Porton Pharma Solutions Ltd. is an internationally recognized pharmaceutical contract development and manufacturing organization (CDMO) in enabling our global clients to optimize drug development and manufacturing. We provide customer development and manufacturing services for small molecule APIs, TIDES, Biologics and Gene & Cell Therapies from pre-clinical to commercialization. A Customer-Centric, Innovative, and Reliable CDMO with Global Solutions.

  • US
  • 2022
    On CPHI since
  • 5000+
    Employees
Company types
CMO/CDMO
Contact info
Meet us at

CPHI Americas 2025

Pennsylvania Convention Center, Philadelphia
20 May 2025 - 22 May 2025

Porton USA LLC Resources (1)

  • Webinar Co-processing: A Multifaceted Approach for Enhancing Density & Powder Flow

    Discover the Power of Co-processing: Unleashing the Potential of Pharmaceutical Manufacturing. Our multifaceted co-processing technology is a game-changer, boosting density, optimizing powder flow, ensuring content uniformity, and enhancing solubility-dissolution. But that's not all – it also goes above and beyond, safeguarding your workforce from potent Active Pharmaceutical Ingredients (APIs). Embrace innovation and efficiency with our cutting-edge co-processing solutions and elevate your pharmaceutical production to new heights. Experience the future of manufacturing! Understand the potential of co-processing technology - what are the key benefits over existing solutions? Discover how the industry is embracing co-processing technology Learn some of the common techniques on the co-processing technology platform See examples of how co-processing can improve powder flow and density, and improve formulation rigidity